StockInvest_us Posted - 5 days ago

Signal alert: $PTCT - Oversold Trend Short (Undervalued) https://stockinvest.us/l/HkOI6CCylI

Stock_Titan Posted - 5 days ago

$PTCT PTC Therapeutics to Host Conference Call to Discuss First Quarter 2024 Financial Results https://www.stocktitan.net/news/PTCT/ptc-therapeutics-to-host-conference-call-to-discuss-first-quarter-j1y2b7mxgvnw.html

insiderbuyingselling Posted - 1 week ago

$PTCT new insider selling: 526 shares. http://insiderbuyingselling.com/?t=PTCT

StockInvest_us Posted - 03/30/24

Signal alert: $PTCT - PivotPoint bottom https://stockinvest.us/l/NP2eb9Q97X

Stock_Titan Posted - 03/28/24

$PTCT PTC Announces Submission of Sepiapterin MAA for Treatment of PKU to EMA https://www.stocktitan.net/news/PTCT/ptc-announces-submission-of-sepiapterin-maa-for-treatment-of-pku-to-8gs7ll0nipji.html

Stock_Titan Posted - 03/19/24

$PTCT PTC Therapeutics Provides Key Regulatory Updates https://www.stocktitan.net/news/PTCT/ptc-therapeutics-provides-key-regulatory-ua9gffsjqmq8.html

VrtcIl Posted - 1 month ago

Do not chase $PTCT and wait for consolidations to enter with defined risk. Monitoring the chart during consolidation phases can offer more controlled and calculated trades. Price: 32.14 Float: 72.9M Short Float: 14.3 % 💰 Dollar Volume: 21.7K ℹ️ USA | Biotechnology

_StockTrader Posted - 1 month ago

Real-Time Stock Data $PTCT Price: 31.8 Volume: 1082923 Market Cap: 2401613312 PE Ratio: -6.377756 Stock data provided by: AITX

Fullratio Posted - 1 month ago

$PTCT current ratio has surged by 84% QoQ and by 18% YoY: https://fullratio.com/stocks/nasdaq-ptct/ptc-therapeutics

VrtcIl Posted - 1 month ago

Exercise patience and wait for pullbacks in $PTCT as potential opportunities for entering positions at safer and more advantageous points. Monitoring the chart during these retracements can provide a more strategic and risk-averse entry. Price: 29.31 Float: 72.9M Short Float: 14.3 % 💰 Dollar Volume: 680.2K ℹ️ USA | Biotechnology

DonCorleone77 Posted - 02/29/24

$PTCT PTC Therapeutics sees FY24 revenue $600M-$680M, consensus $612.29M

DonCorleone77 Posted - 02/29/24

$PTCT PTC Therapeutics reports Q4 EPS ($2.06), consensus 50c Reports Q4 revenue $307.1M, consensus $321.29M. "We closed out 2023 with strong revenue performance in the fourth quarter," said Matthew Klein, M.D., Chief Executive Officer, PTC Therapeutics, Inc. "We are well-positioned for a successful 2024 with several potential exciting clinical and regulatory milestones ahead. We look forward to initiating the global regulatory submissions for sepiapterin for the treatment of PKU, which we see as a potential billion-dollar opportunity, as well as to advancing our PTC518, vatiquinone, and utreloxastat programs."

epsguid Posted - 02/29/24

$PTCT reported a loss of $2.06, consensus was $0.29 via @eWhispers #epsmiss http://eps.sh/d/ptct

Stock_Titan Posted - 02/29/24

$PTCT PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results https://www.stocktitan.net/news/PTCT/ptc-therapeutics-provides-corporate-update-and-reports-fourth-2dcfserr6ncx.html

Stock_Titan Posted - 02/27/24

$PTCT PTC Therapeutics to Participate at Upcoming Investor Conferences https://www.stocktitan.net/news/PTCT/ptc-therapeutics-to-participate-at-upcoming-investor-fi9o340mdqcf.html

Stock_Titan Posted - 02/22/24

$PTCT PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://www.stocktitan.net/news/PTCT/ptc-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-0bm3b5pginhy.html

Stock_Titan Posted - 2 months ago

$PTCT PTC Therapeutics to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results https://www.stocktitan.net/news/PTCT/ptc-therapeutics-to-host-conference-call-to-discuss-fourth-quarter-k3txy24qjc68.html

DonCorleone77 Posted - 2 months ago

$PTCT PTC Therapeutics price target lowered to $43 from $45 at JPMorgan JPMorgan lowered the firm's price target on PTC Therapeutics to $43 from $45 and keeps an Overweight rating on the shares. The analyst cites reduced forecasts for Tegsedi and Upstaza for the target drop.

david102 Posted - 01/31/24

@Ainvest_Newswire that is $PTCT not $PTC, which is a software company.

Bugseason Posted - 01/26/24

$RNA $DYN Has a rumor of buyout But $RNA has better science double the cash and $PTCT therapeutics just got dropped from Europe for their duchenne drug so a combo of these speculations have $RNA heading to $25

OpenOutcrier Posted - 01/26/24

$PTCT (-10.0% pre) PTC Therapeutics Shares Drop After Negative Opinion From CHMP - MW https://ooc.bz/l/23206

neelsen01 Posted - 01/26/24

$PTCT $20 level on watch…

traderstatusquo92 Posted - 01/25/24

$PTCT * sorry typo

Last10K Posted - 01/25/24

$PTCT just filed with the SEC a Regulated Disclosure and a Financial Exhibit https://last10k.com/sec-filings/PTCT/0001070081-24-000006.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=PTCT

cctranscripts Posted - 01/24/24

Statement of acquisition of beneficial ownership by individuals https://www.conferencecalltranscripts.org/summary/?id=12891386 $PTCT

cctranscripts Posted - 01/22/24

Report of proposed sale of securities https://www.conferencecalltranscripts.org/summary/?id=12884304 $PTCT

tickeron Posted - 01/17/24

$PTCT enters bullish trend https://srnk.us/go/4971438

ChartMill Posted - 01/17/24

Most gaining stocks today: $PTCT, $IEP, $FHI, $ESTC and $ELF https://www.chartmill.com/stock/stock-screener?v=3&f=sl_pt_4_X,p_pg10,v1_50b500,exch_us&s=pt&utm_source=top_gainers&utm_medium=stocktwits&utm_campaign=screen

tickeron Posted - 3 months ago

$PTCT 6 Insiders at PTC Therapeutics sold 13,845 shares last week for $401.6K https://srnk.us/go/4969143

tickeron Posted - 3 months ago

$PTCT enters bullish trend https://srnk.us/go/4968126